Concomitant treatments. Results are shown as the number of patients receiving each treatment
Ciprofloxacin group (n=36) | Placebo group (n=35) | |
Glucocorticoids | ||
Systemic | 6 | 4 |
Intra-articular | 224-151 | 184-151 |
NSAIDs4-150 | 36 | 34 |
DMARDs4-150 | ||
Sulfasalazine | 7 | 3 |
Methotrexate | 1 | 0 |
Systemic antimicrobial drugs | ||
Before randomisation | 22 | 21 |
Concomitant | 4 | 5 |
Other drugs | 9 | 10 |